CREB-1 Antibodies

Santa Cruz Biotechnology features a diverse variety of CREB-1 monoclonal antibodies for research focused on cAMP response element-binding protein 1 (CREB-1). CREB-1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CREB-1 functions as a transcription factor that regulates gene expression in response to cellular signals, with essential roles in neuronal plasticity, memory formation, and metabolic regulation. Dysregulation of CREB-1 has been linked to various diseases, including cancer and neurodegenerative disorders, highlighting its importance as a therapeutic target. Understanding CREB-1's function and regulation continues to be crucial for advancing research in multiple fields. Researchers can utilize CREB-1 monoclonal antibodies to investigate cellular pathways and molecular mechanisms. The specificity and reliability of CREB-1 monoclonal antibodies enable precise detection and analysis of protein expression, localization, and interactions. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific understanding of cellular processes and disease mechanisms.